BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9338096)

  • 1. Cyclins and the G2/M transition.
    Jackman MR; Pines JN
    Cancer Surv; 1997; 29():47-73. PubMed ID: 9338096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal control of the dephosphorylation of Cdk substrates by mitotic exit pathways in budding yeast.
    Jin F; Liu H; Liang F; Rizkallah R; Hurt MM; Wang Y
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16177-82. PubMed ID: 18845678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
    Ruiz EJ; Hunt T; Nebreda AR
    Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
    Morris MC; Divita G
    J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple cyclin-dependent kinase complexes and phosphatases control G2/M progression in alfalfa cells.
    Mészáros T; Miskolczi P; Ayaydin F; Pettkó-Szandtner A; Peres A; Magyar Z; Horváth GV; Bakó L; Fehér A; Dudits D
    Plant Mol Biol; 2000 Aug; 43(5-6):595-605. PubMed ID: 11089863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cdc25A phosphatase has a non-redundant function in G2 phase by activating Cyclin A-dependent kinases.
    Timofeev O; Cizmecioglu O; Hu E; Orlik T; Hoffmann I
    FEBS Lett; 2009 Feb; 583(4):841-7. PubMed ID: 19192479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107.
    Chibazakura T; McGrew SG; Cooper JA; Yoshikawa H; Roberts JM
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4465-70. PubMed ID: 15070741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination of G2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1.
    Gong J; Traganos F; Darzynkiewicz Z
    Exp Cell Res; 1995 Sep; 220(1):226-31. PubMed ID: 7664839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of CDC25A on SER283 in late S/G2 by CDK/cyclin complexes accelerates mitotic entry.
    Mazzolini L; Broban A; Froment C; Burlet-Schiltz O; Besson A; Manenti S; Dozier C
    Cell Cycle; 2016 Oct; 15(20):2742-52. PubMed ID: 27580187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From simple to complex patterns of oscillatory behavior in a model for the mammalian cell cycle containing multiple oscillatory circuits.
    Gérard C; Goldbeter A
    Chaos; 2010 Dec; 20(4):045109. PubMed ID: 21198121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14-3-3 proteins in cell cycle regulation.
    Hermeking H; Benzinger A
    Semin Cancer Biol; 2006 Jun; 16(3):183-92. PubMed ID: 16697662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates.
    Suryadinata R; Sadowski M; Sarcevic B
    Biosci Rep; 2010 Mar; 30(4):243-55. PubMed ID: 20337599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for cyclin A1 in the activation of MPF and G2-M transition during meiosis of male germ cells in mice.
    Liu D; Liao C; Wolgemuth DJ
    Dev Biol; 2000 Aug; 224(2):388-400. PubMed ID: 10926775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
    Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anaphase promoting complex.
    Page AM; Hieter P
    Cancer Surv; 1997; 29():133-50. PubMed ID: 9338100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells.
    Clemens DL; Calisto LE; Sorrell MF; Tuma DJ
    Hepatology; 2003 Aug; 38(2):385-93. PubMed ID: 12883482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cdc25 phosphatase is essential for the G2/M phase transition in the basidiomycete yeast Ustilago maydis.
    Sgarlata C; Pérez-Martín J
    Mol Microbiol; 2005 Dec; 58(5):1482-96. PubMed ID: 16313631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division.
    John PC; Mews M; Moore R
    Protoplasma; 2001; 216(3-4):119-42. PubMed ID: 11732181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.